ACSL6 is associated with the number of cigarettes smoked and its expression is altered by chronic nicotine exposure

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Chen, Jingchun ^a   Brunzell, Darlene H ^b   Jackson, Kia ^a   van der Vaart, Andrew ^c   Ma, Jennie Z ^d   Payne, Thomas J ^e   Sherva, Richard ^f   Farrer, Lindsay A ^f   Gejman, Pablo ^g   Levinson, Douglas F ^h   Holmans, Peter ⁱ   Aggen, Steven H ^a   Damaj, Imad ^b   Kuo, Po Hsiu ^j   Webb, Bradley T ^a   Anton, Raymond ^k   Kranzler, Henry R ^l   Gelernter, Joel ^m,n   Li, Ming D ^c   Kendler, Kenneth S ^a,b   Chen, Xiangning ^a,b   more..

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^h STANFORD UNIVERSITY   (United States)

ⁱ CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^j NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^k MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^l UNIVERSITY OF PENNSYLVANIA   (United States)

^m YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; MECAMYLAMINE; MESSENGER RNA; NICOTINE; NICOTINIC RECEPTOR; PROTEIN ACSL6; UNCLASSIFIED DRUG; ACSL6 PROTEIN, HUMAN; LONG CHAIN FATTY ACID COENZYME A LIGASE; NICOTINIC RECEPTOR BLOCKING AGENT;

ACSL6 GENE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN TISSUE; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC VARIABILITY; HIPPOCAMPUS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LONG TERM EXPOSURE; MALE; MOLECULAR GENETICS; MOUSE; NEWBORN; NONHUMAN; OSMOTIC MINIPUMP; PREFRONTAL CORTEX; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; REPLICATION STUDY; SCHIZOPHRENIA; ADOLESCENT; ADULT; AGED; ANIMAL; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TIME;

ADOLESCENT; ADULT; AGED; ANIMALS; COENZYME A LIGASES; ENVIRONMENTAL EXPOSURE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MECAMYLAMINE; MICE; MIDDLE AGED; NICOTINE; NICOTINIC ANTAGONISTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RATS; RECEPTORS, NICOTINIC; RNA, MESSENGER; SCHIZOPHRENIA; SMOKING; TIME FACTORS; YOUNG ADULT;

EID: 83755196447     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028790     Document Type: Article

References (86)

1. Saccone SF, Hinrichs AL, Saccone NL, Chase GA, Konvicka K, et al. (2007) Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 16: 36-49.
2. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, et al. (2008) A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452: 638-642.
3. Berrettini W, Yuan X, Tozzi F, Song K, Francks C, et al. (2008) Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol Psychiatry 13: 368-373.
4. Batel P, (2000) Addiction and schizophrenia. Eur Psychiatry 15: 115-122.
5. Salin-Pascual RJ, Alcocer-Castillejos NV, Alejo-Galarza G, (2003) Nicotine dependence and psychiatric disorders. Rev Invest Clin 55: 677-693.
6. de Leon J, Diaz FJ, (2005) A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 76: 135-157.
7. Kumari V, Postma P, (2005) Nicotine use in schizophrenia: the self medication hypotheses. Neurosci Biobehav Rev 29: 1021-1034.
8. Leonard S, Mexal S, Freedman R, (2007) Smoking, Genetics and Schizophrenia: Evidence for Self Medication. J Dual Diagn 3: 43-59.
9. Chen X, Wang X, Hossain S, O'Neill FA, Walsh D, et al. (2006) Haplotypes spanning SPEC2, PDZ-G EF2 and ACSL6 genes are associated with schizophrenia. Hum Mol Genet 15: 3329-3342.
10. Le Foll B, Goldberg SR, (2009) Effects of nicotine in experimental animals and humans: an update on addictive properties. Handb Exp Pharmacol 192: 335-367.
11. Jackson KJ, Martin BR, Changeux JP, Damaj MI, (2008) Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. J Pharmacol Exp Ther 325: 302-312.
12. Jackson KJ, McIntosh JM, Brunzell DH, Sanjakdar SS, Damaj MI, (2009) The role of alpha6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal. J Pharmacol Exp Ther 331: 547-554.
13. Van Horn CG, Caviglia JM, Li LO, Wang S, Granger DA, et al. (2005) Characterization of recombinant long-chain rat acyl-CoA synthetase isoforms 3 and 6: identification of a novel variant of isoform 6. Biochemistry 44: 1635-1642.
14. Wang J, Ueda N, (2009) Biology of endocannabinoid synthesis system. Prostaglandins Other Lipid Mediat 89: 112-119.
15. Comings DE, Muhleman D, Gade R, Johnson P, Verde R, et al. (1997) Cannabinoid receptor gene (CNR1): association with i.v. drug use. Mol Psychiatry 2: 161-168.
16. Schmidt LG, Samochowiec J, Finckh U, Fiszer-Piosik E, Horodnicki J, et al. (2002) Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence. Drug Alcohol Depend 65: 221-224.
17. Zuo L, Kranzler HR, Luo X, Covault J, Gelernter J, (2007) CNR1 Variation Modulates Risk for Drug and Alcohol Dependence. Biol Psychiatry 62: 616-626.
18. Chen X, Williamson VS, An SS, Hettema JM, Aggens HS, et al. (2008) The cannabinoid receptor 1 (CNR1) gene association with nicotine dependence. Arch Gen Psychiatry 65: 816-824.
19. Forget B, Hamon M, Thiebot MH, (2005) Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats. Psychopharmacology (Berl) 181: 722-734.
20. Merritt LL, Martin BR, Walters C, Lichtman AH, Damaj MI, (2008) The endogenous cannabinoid system modulates nicotine reward and dependence. J Pharmacol Exp Ther 326: 483-492.
21. Shoaib M, (2008) The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats. Neuropharmacology 54: 438-444.
22. Arnold JC, (2005) The role of endocannabinoid transmission in cocaine addiction. Pharmacol Biochem Behav 81: 396-406.
23. Colombo G, Serra S, Vacca G, Carai MA, Gessa GL, (2005) Endocannabinoid system and alcohol addiction: pharmacological studies. Pharmacol Biochem Behav 81: 369-380.
24. Fattore L, Cossu G, Spano MS, Deiana S, Fadda P, et al. (2004) Cannabinoids and reward: interactions with the opioid system. Crit Rev Neurobiol 16: 147-158.
25. Lupica CR, Riegel AC, Hoffman AF, (2004) Marijuana and cannabinoid regulation of brain reward circuits. Br J Pharmacol 143: 227-234.
26. Maldonado R, Valverde O, Berrendero F, (2006) Involvement of the endocannabinoid system in drug addiction. Trends Neurosci 29: 225-232.
27. Racz I, Bilkei-Gorzo A, Toth ZE, Michel K, Palkovits M, et al. (2003) A critical role for the cannabinoid CB1 receptors in alcohol dependence and stress-stimulated ethanol drinking. J Neurosci 23: 2453-2458.
28. Zhang PW, Ishiguro H, Ohtsuki T, Hess J, Carillo F, et al. (2004) Human cannabinoid receptor 1: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse. Mol Psychiatry 9: 916-931.
29. Fernandez-Espejo E, Viveros MP, Nunez L, Ellenbroek BA, Rodriguez de FF, (2009) Role of cannabis and endocannabinoids in the genesis of schizophrenia. Psychopharmacology (Berl) 206: 531-549.
30. van OJ, Kenis G, Rutten BP, (2010) The environment and schizophrenia. Nature 468: 203-212.
31. Goldman-Rakic PS, (1994) Working memory dysfunction in schizophrenia. J Neuropsychiatry Clin Neurosci 6: 348-357.
32. Arnold OH, (1999) Schizophrenia- A disturbance of signal interaction between the entorhinal cortex and the dentate gyrus? The contribution of experimental dibenamine psychosis to the pathogenesis of schizophrenia: A hypothesis. Neuropsychobiology 40: 21-32.
33. Tamminga CA, Stan AD, Wagner AD, (2010) The hippocampal formation in schizophrenia. Am J Psychiatry 167: 1178-1193.
34. van Erp TG, Therman S, Pirkola T, Tuulio-Henriksson A, Glahn DC, et al. (2008) Verbal recall and recognition in twins discordant for schizophrenia. Psychiatry Res 159: 271-280.
35. Jackson KJ, Walters CL, Miles MF, Martin BR, Damaj MI, (2009) Characterization of pharmacological and behavioral differences to nicotine in C57Bl/6 and DBA/2 mice. Neuropharmacology 57: 347-355.
36. Fattore L, Fadda P, Spano MS, Pistis M, Fratta W, (2008) Neurobiological mechanisms of cannabinoid addiction. Mol Cell Endocrinol 286: S97-S107.
37. Feltenstein MW, See RE, (2008) The neurocircuitry of addiction: an overview. Br J Pharmacol 154: 261-274.
38. Di MV, Pierucci M, Di GG, Benigno A, Esposito E, (2007) The neurobiological bases for the pharmacotherapy of nicotine addiction. Curr Pharm Des 13: 1269-1284.
39. McClernon FJ, Kozink RV, Rose JE, (2008) Individual differences in nicotine dependence, withdrawal symptoms, and sex predict transient fMRI-BOLD responses to smoking cues. Neuropsychopharmacology 33: 2148-2157.
40. Salas R, Sturm R, Boulter J, De Biasi M, (2009) Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice. J Neurosci 29: 3014-3018.
41. Mansvelder HD, Mertz M, Role LW, (2009) Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits. Semin Cell Dev Biol 20: 432-440.
42. Brody AL, Mandelkern MA, Jarvik ME, Lee GS, Smith EC, et al. (2004) Differences between smokers and nonsmokers in regional gray matter volumes and densities. Biol Psychiatry 55: 77-84.
43. Brody AL, Mandelkern MA, London ED, Childress AR, Lee GS, et al. (2002) Brain metabolic changes during cigarette craving. Arch Gen Psychiatry 59: 1162-1172.
44. Uhl GR, Drgon T, Liu QR, Johnson C, Walther D, et al. (2008) Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Arch Gen Psychiatry 65: 345-355.
45. De LV, Voineskos S, Wong G, Kennedy JL, (2006) Genetic interaction between alpha4 and beta2 subunits of high affinity nicotinic receptor: analysis in schizophrenia. Exp Brain Res 174: 292-296.
46. De LV, Wong AH, Muller DJ, Wong GW, Tyndale RF, et al. (2004) Evidence of association between smoking and alpha7 nicotinic receptor subunit gene in schizophrenia patients. Neuropsychopharmacology 29: 1522-1526.
47. Voineskos S, De Luca V, Mensah A, Vincent JB, Potapova N, et al. (2007) Association of alpha4beta2 nicotinic receptor and heavy smoking in schizophrenia. J Psychiatry Neurosci 32: 412-416.
48. Thorgeirsson TE, Gudbjartsson DF, Surakka I, Vink JM, Amin N, et al. (2010) Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet 42: 448-453.
49. Jacobsen LK, D'Souza DC, Mencl WE, Pugh KR, Skudlarski P, et al. (2004) Nicotine effects on brain function and functional connectivity in schizophrenia. Biol Psychiatry 55: 850-858.
50. Rezvani AH, Levin ED, (2001) Cognitive effects of nicotine. Biol Psychiatry 49: 258-267.
51. Sacco KA, Termine A, Seyal A, Dudas MM, Vessicchio JC, et al. (2005) Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry 62: 649-659.
52. Moss TG, Sacco KA, Allen TM, Weinberger AH, Vessicchio JC, et al. (2009) Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia. Drug Alcohol Depend 104: 94-99.
53. Pattij T, Wiskerke J, Schoffelmeer AN, (2008) Cannabinoid modulation of executive functions. Eur J Pharmacol 585: 458-463.
54. Solowij N, Battisti R, (2008) The chronic effects of cannabis on memory in humans: a review. Curr Drug Abuse Rev 1: 81-98.
55. Robinson L, Goonawardena AV, Pertwee R, Hampson RE, Platt B, et al. (2010) WIN55,212-2 induced deficits in spatial learning are mediated by cholinergic hypofunction. Behav Brain Res 208: 584-592.
56. Goonawardena AV, Robinson L, Hampson RE, Riedel G, (2010) Cannabinoid and cholinergic systems interact during performance of a short-term memory task in the rat. Learn Mem 17: 502-511.
57. Beuten J, Ma JZ, Payne TJ, Dupont RT, Quezada P, et al. (2005) Significant association of BDNF haplotypes in European-American male smokers but not in European-American female or African-American smokers. Am J Med Genet B Neuropsychiatr Genet 139B: 73-80.
58. Ho BC, Andreasen NC, Dawson JD, Wassink TH, (2007) Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am J Psychiatry 164: 1890-1899.
59. Neves-Pereira M, Cheung JK, Pasdar A, Zhang F, Breen G, et al. (2005) BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 10: 208-212.
60. Qian L, Zhao J, Shi Y, Zhao X, Feng G, et al. (2007) Brain-derived neurotrophic factor and risk of schizophrenia: an association study and meta-analysis. Biochem Biophys Res Commun 353: 738-743.
61. Zintzaras E, (2007) Brain-derived neurotrophic factor gene polymorphisms and schizophrenia: a meta-analysis. Psychiatr Genet 17: 69-75.
62. Tsai SJ, Wang YC, Hong CJ, (2000) Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia. Psychiatr Genet 10: 149-151.
63. Chavarria-Siles I, Contreras-Rojas J, Hare E, Walss-Bass C, Quezada P, et al. (2008) Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia. Am J Med Genet B Neuropsychiatr Genet 147: 279-284.
64. Martinez-Gras I, Hoenicka J, Ponce G, Rodriguez-Jimenez R, Jimenez-Arriero MA, et al. (2006) (AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population. Eur Arch Psychiatry Clin Neurosci 256: 437-441.
65. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, et al. (2009) Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460: 753-757.
66. Bierut LJ, Saccone NL, Rice JP, Goate A, Foroud T, et al. (2002) Defining alcohol-related phenotypes in humans. The Collaborative Study on the Genetics of Alcoholism. Alcohol Res Health 26: 208-213.
67. Bierut LJ, Strickland JR, Thompson JR, Afful SE, Cottler LB, (2008) Drug use and dependence in cocaine dependent subjects, community-based individuals, and their siblings. Drug Alcohol Depend 95: 14-22.
68. Landi MT, Consonni D, Rotunno M, Bergen AW, Goldstein AM, et al. (2008) Environment And Genetics in Lung cancer Etiology (EAGLE) study: an integrative population-based case-control study of lung cancer. BMC Public Health 8: 203-212.
69. Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, et al. (2000) Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 21: 273S-309S.
70. Simpson NK, Johnson CC, Ogden SL, Gamito E, Trocky N, et al. (2000) Recruitment strategies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: the first six years. Control Clin Trials 21: 356S-378S.
71. Kendler KS, Neale MC, Sullivan P, Corey LA, Gardner CO, et al. (1999) A population-based twin study in women of smoking initiation and nicotine dependence. Psychol Med 29: 299-308.
72. Kendler KS, Prescott CA, (2007) Genes, Environment, and Psychopathology: Understanding the Causes of Psychiatric and Substance Use Disorders New York Guilford Press.
73. Prescott CA, Kendler KS, (1999) Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins. Am J Psychiatry 156: 34-40.
74. Fagerstrom KO, Schneider NG, (1989) Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med 12: 159-182.
75. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO, (1991) The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86: 1119-1127.
76. Huang W, Payne TJ, Ma JZ, Beuten J, Dupont RT, et al. (2009) Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample. Neuropsychopharmacology 34: 319-330.
77. Li MD, Sun D, Lou XY, Beuten J, Payne TJ, et al. (2007) Linkage and association studies in African- and Caucasian-American populations demonstrate that SHC3 is a novel susceptibility locus for nicotine dependence. Mol Psychiatry 12: 462-473.
78. Li MD, Beuten J, Ma JZ, Payne TJ, Lou XY, et al. (2005) Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. Hum Mol Genet 14: 1211-1219.
79. Sherva R, Kranzler HR, Yu Y, Logue MW, Poling J, et al. (2010) Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes. Neuropsychopharmacology 35: 1921-1931.
80. Stephens M, Sloan JS, Robertson PD, Scheet P, Nickerson DA, (2006) Automating sequence-based detection and genotyping of SNPs from diploid samples. Nat Genet 38: 375-381.
81. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
82. Magi R, Morris AP, (2010) GWAMA: software for genome-wide association meta-analysis. BMC Bioinformatics 11: 288-294.
83. McKinney JS, Willoughby KA, Liang S, Ellis EF, (1996) Stretch-induced injury of cultured neuronal, glial, and endothelial cells. Effect of polyethylene glycol-conjugated superoxide dismutase. Stroke 27: 934-940.
84. Chen T, Willoughby KA, Ellis EF, (2004) Group I metabotropic receptor antagonism blocks depletion of calcium stores and reduces potentiated capacitative calcium entry in strain-injured neurons and astrocytes. J Neurotrauma 21: 271-281.
85. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
86. Jackson KJ, Chen Q, Chen J, Aggen SH, Kendler KS, et al. (2010) Association of the histidine-triad nucleotide-binding protein-1 (HINT1) gene variants with nicotine dependence. Pharmacogenomics J 11: 251-257.